Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

“We have to plan beyond a four-year plan and plan a 40-year plan that outlives any administration,” said Robert Bullard, a leader of the movement. BALTIMORE — The environmental justice movement must ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

Chart Industries (NYSE:GTLS) +17.1% post-market Monday after the Financial Times reported Baker Hughes (NASDAQ:BKR) is near a $13.6B cash deal to acquire the company, valuing Chart at $210/share, a 22 ...

There comes a time before every big purchase when you might ask yourself, “Do I really need this?” If you don’t pause for a moment — and if you tend to blow your budget as a result — then you need to ...

Chart Industries and Flowserve recently agreed to merge in an all-stock deal. The two companies outlined significant revenue and cost synergies. Strangely, both bargain-priced stocks fell after the ...

June 4 (Reuters) - U.S.-based equipment manufacturer Chart Industries (GTLS.N), opens new tab and flow control systems maker Flowserve Corp (FLS.N), opens new tab agreed to merge in an all-stock deal, ...